Very low bilirubin after portoenterostomy improves survival of the native liver in patients with biliary atresia by deferring liver fibrogenesis

Gallbladder and Biliary Diseases

Prognostic markers at adolescence in patients Biliary Atresia for liver transplantation in adulthood

J Hepatol.

Jain V, Burford C, Alexander EC, Sutton H, Dhawan A, Joshi D, Davenport M, Heaton N, Hadzic N, Samyn M

doi: 10.1016/j.jhep.2019.03.005.

Gallbladder and Biliary Diseases

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

Am J Gastroenterol.

Murillo Perez CF, Harms MH, Lindor KD, van Buuren HR, Hirschfield GM, Corpechot C, van der Meer AJ, Feld JJ, Gulamhusein A, Lammers WJ, Ponsioen CY, Carbone M, Mason AL, Mayo MJ, Invernizzi P, Battezzati PM, Floreani A, Lleo A, Nevens F, Kowdley KV, Bruns T, Dalekos GN, Gatselis NK, Thorburn D, Trivedi PJ, Verhelst X, Parés A, Janssen HLA, Hansen BE, GLOBAL PBC Study Group.

doi: 10.14309/ajg.

Hepatology

Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival

Aliment Pharmacol Ther.

Huebener P, Sterneck MR, Bangert K, Drolz A, Lohse AW, Kluge S, Fischer L, Fuhrmann V

doi: 10.1111/apt.14627.

Hepatology

Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis

Dig Dis Sci.

Jara M, Dziodzio T, Malinowski M, Lüttgert K, Nikolov R, Ritschl PV, Öllinger R, Pratschke J, Stockmann M

doi: 10.1007/s10620-018-5360-5.

Hepatology

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia

Wang S, Zhang X, Han T, Xie W, Li Y, Ma H, Liebe R, Weng H, Ding HG

doi: 10.1186/s12876-018-0857-0.

Gallbladder and Biliary Diseases

Impact of Steroid Therapy on Early Growth in Infants with Biliary Atresia: The Multicenter Steroids in Biliary Atresia Randomized Trial

J Pediatr.

Alonso EM, Ye W, Hawthorne K, Venkat V, Loomes KM, Mack CL, Hertel PM, Karpen SJ, Kerkar N, Molleston JP, Murray KF, Romero R, Rosenthal P, Schwarz KB, Shneider BL, Suchy FJ, Turmelle YP, Wang KS, Sherker AH, Sokol RJ, Bezerra JA, Magee JC; ChiLDReN Network

doi: 10.1016/j.jpeds.2018.07.002.

Gallbladder and Biliary Diseases

Improved markers of cholestatic liver injury in patients with primary biliary cholangitis treated with obeticholic acid and bezafibrate

Hepatology

Smets L, Verbeek J, Korf H, van der Merwe S, Nevens F

doi: 10.1002/hep.31613

Hepatology

Vitamin E Improves Transplant-free Survival and Hepatic Decompensation among Patients with NASH and Advanced Fibrosis

doi: 10.1002/hep.30368.

Gallbladder and Biliary Diseases

Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis

BMC Gastroenterol.

Fujino H, Tanaka M, Imamura M, Morio K, Ono A, Nakahara T, Murakami E, Kawaoka T, Takahashi S, Miki D, Tsuge M, Hiramatsu A, Aikata H, Hayes CN, Chayama K

doi: 10.1186/s12876-019-1092-z.

Related content

Prognostic markers at adolescence in patients Biliary Atresia for liver transplantation in adulthood

Goals of Treatment for Improved Survival in Primary Biliary Cholangitis: Treatment Target Should Be Bilirubin Within the Normal Range and Normalization of Alkaline Phosphatase

Stabilisation of acute-on-chronic liver failure patients before liver transplantation predicts post-transplant survival

Prospective Assessment of Liver Function by an Enzymatic Liver Function Test to Estimate Short-Term Survival in Patients with Liver Cirrhosis

Tolvaptan treatment improves survival of cirrhotic patients with ascites and hyponatremia

Impact of Steroid Therapy on Early Growth in Infants with Biliary Atresia: The Multicenter Steroids in Biliary Atresia Randomized Trial

Improved markers of cholestatic liver injury in patients with primary biliary cholangitis treated with obeticholic acid and bezafibrate

Vitamin E Improves Transplant-free Survival and Hepatic Decompensation among Patients with NASH and Advanced Fibrosis

Pruritus in patients with chronic liver disease and serum autotaxin levels in patients with primary biliary cholangitis